A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults.

Title:	A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults.
Authors:	Omosa-Manyonyi, G Mpendo, J Ruzagira, E Kilembe, W Chomba, E Roman, F Bourguignon, P Koutsoukos, M Collard, A Voss, G Laufer, D Stevens, G Hayes, P Clark, L Cormier, E Dally, L Barin, B Ackland, J Syvertsen, K Zachariah, D Anas, K Sayeed, E Lombardo, A Gilmour, J Cox, J Fast, P Priddy, F
Item Type:	Journal Article
Issue Date:	11-May-2015
URI:	http://hdl.handle.net/10044/1/23268
DOI:	https://dx.doi.org/10.1371/journal.pone.0125954
ISSN:	1932-6203
Start Page:	e0125954
Journal / Book Title:	PLoS One
Volume:	10
Issue:	5
Copyright Statement:	© 2015 Kamali et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conference Place:	United States
Appears in Collections:	Department of Medicine (up to 2019)

This item is licensed under a Creative Commons License